Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
細胞特性(日)
骨運動器疾患関連。NM6s : Myotubularin related protein 6 (1-100(100aa))を抗原として作製したハイブリドーマ。
細胞特性(寄託者記述:英)
Myotubularin related protein 6 (1-100(100aa)) was expressed on the surface of baculovirus as the gp64-fusion protein according to the previously described procedure ( J.Immunol,Methods. 234, 123-135, 2000). This hybridoma was generated using the recombinant budded virus as an immunogen.
細胞特性(寄託者記述:日)
Myotubularin related protein 6 (1-100(100aa)) を、バキュロウイルスのエンヴェロープタンパク質上にgp64-fusionタンパク質として発現させ ( J.Immunol,Methods. 234, 123-135, 2000)、ウイルス粒子(発芽ウイルス)を回収して免疫し、作製したハイブリドーマ。免疫動物は、gp64 transgenic mouse(ref. J.Immunol,Methods. 30: 322(1-2), 114-117, 2007)。
使用条件(英)
1) Publishing the works using these antibodies, please acknowledge that their production was supported by the project of "Development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO)". 2) No recipient shall use the research material, their progeny or derivatives, commercially without depositor's prior written approval.
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).